One infusion of ciltacabtagene autoleucel led to minimal residual disease negativity in all patients, and there were no progressions to a...

AACR· @AACR · X·2026-04-20 23:10· 2026-04-20评分60

正文 · 机器翻译

单次输注 ciltacabtagene autoleucel 使所有患者达到微小残留病阴性，且在中位随访 15.3 个月期间，无进展为活动性多发性骨髓瘤。#AACR26

热度 2 · 1 赞 · 0 回复 · 1 转发

来源：AACR · x.com